Invention Grant
- Patent Title: Tyrosine kinase inhibitor and pharmaceutical composition comprising same
-
Application No.: US15562825Application Date: 2016-04-07
-
Publication No.: US10654808B2Publication Date: 2020-05-19
- Inventor: Chaofeng Long , Zhengxia Chen , Xiaoxin Chen , Yang Zhang , Zhuowei Liu , Peng Li , Shuhui Chen , Guibai Liang , Cheng Xie , Zhengwei Li , Zhifei Fu , Guoping Hu , Jian Li
- Applicant: GUANGDONG RAYNOVENT BIOTECH CO., LTD.
- Applicant Address: CN Guangdong
- Assignee: GUANGDONG RAYNOVENT BIOTECH CO., LTD.
- Current Assignee: GUANGDONG RAYNOVENT BIOTECH CO., LTD.
- Current Assignee Address: CN Guangdong
- Agency: Lewis Roca Rothgerber Christie LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@7fb98837
- International Application: PCT/CN2016/078703 WO 20160407
- International Announcement: WO2016/161952 WO 20161013
- Main IPC: C07D215/48
- IPC: C07D215/48 ; C07D405/14 ; C07F9/60 ; C07D401/12 ; C07D417/12 ; C07D498/04 ; C07D491/056 ; A61K31/4709 ; A61K31/53 ; A61P35/00 ; C07D401/10 ; C07D401/14 ; C07D405/12 ; C07D417/10 ; C07D471/04 ; C07D487/04
Abstract:
The present invention relates to a tyrosine kinase inhibitor and a pharmaceutical composition comprising same. The tyrosine kinase inhibitor of the present invention has the structures as shown in the following formula (I) or (II):
Public/Granted literature
- US20190119217A1 TYROSINE KINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Public/Granted day:2019-04-25
Information query
